CVS Health Posts Modest 0.36% Gain Amid 21.76% Volume Slide Ranks 317th in U.S. Trading Activity

CVS Health (CVS) closed 0.36% higher on October 7, 2025, with a trading volume of $0.36 billion, representing a 21.76% decline from the previous day’s volume. The stock ranked 317th in trading activity among U.S. equities. The modest price gain occurred despite reduced liquidity, suggesting limited short-term investor engagement with the health care giant.

The company’s performance was influenced by mixed market sentiment toward pharmacy chains, though no major earnings reports or regulatory updates directly impacted the stock. Analysts noted that the volume contraction indicated cautious positioning, with traders potentially awaiting clarity on upcoming healthcare policy developments. The price action remained confined within a narrow range, reflecting subdued momentum ahead of key sector-specific catalysts.

To accurately execute the back-test, the following parameters require definition: universe scope (e.g., U.S. listed common stocks), entry/exit pricing methodology (e.g., close-to-close), transaction cost assumptions (e.g., commission or slippage), and weighting approach (e.g., equal-weight or cap-weighted). Once these parameters are finalized, the test can proceed by generating daily “buy list” signals and tracking one-day holding periods from January 3, 2022, to the current date.